Clinical trial
Folate and Protection Against Cervical Cancer
NCT00220532 · Sheffield Teaching Hospitals NHS Foundation Trust, Other · Terminated
Key facts
| NCT number | NCT00220532 |
|---|---|
| Title | Folate and Protection Against Cervical Cancer |
| Official title | A Randomised Placebo-Controlled Trial to Evaluate Interactions Between Riboflavin and Folate Intake and Genotype in Reducing Risk of Cervical Cancer |
| Lead sponsor | Sheffield Teaching Hospitals NHS Foundation Trust, Other |
| Collaborators | World Cancer Research Fund International |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Cervical Cancer |
| Intervention type | Drug |
| Interventions | Folic acid with riboflavin |
| Enrollment | 180 |
| Start date | Jul 1, 2005 |
| Completion | May 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Sep 13, 2006 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: